These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3091604

  • 1. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
    Stump DC, Thienpont M, Collen D.
    J Biol Chem; 1986 Sep 25; 261(27):12759-66. PubMed ID: 3091604
    [Abstract] [Full Text] [Related]

  • 2. Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex.
    Stump DC, Thienpont M, Collen D.
    J Biol Chem; 1986 Jan 25; 261(3):1267-73. PubMed ID: 3080422
    [Abstract] [Full Text] [Related]

  • 3. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
    Moroi M, Aoki N.
    J Biol Chem; 1976 Oct 10; 251(19):5956-65. PubMed ID: 134998
    [Abstract] [Full Text] [Related]

  • 4. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.
    Eaton DL, Scott RW, Baker JB.
    J Biol Chem; 1984 May 25; 259(10):6241-7. PubMed ID: 6373753
    [Abstract] [Full Text] [Related]

  • 5. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H, Stephens RW, Nakagawa T, McNicol D.
    J Biochem; 1988 Dec 25; 104(6):960-7. PubMed ID: 3149640
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I.
    Thromb Haemost; 1978 Jun 30; 39(3):616-23. PubMed ID: 705690
    [Abstract] [Full Text] [Related]

  • 7. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
    Wun TC, Reich E.
    J Biol Chem; 1987 Mar 15; 262(8):3646-53. PubMed ID: 3102492
    [Abstract] [Full Text] [Related]

  • 8. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC, Lijnen HR, Collen D.
    J Biol Chem; 1986 Jan 25; 261(3):1274-8. PubMed ID: 3080423
    [Abstract] [Full Text] [Related]

  • 9. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S.
    Biochem J; 1974 Nov 25; 143(2):273-83. PubMed ID: 4282470
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D, Lijnen HR, Piérard L, de Foresta F, Demarsin E, Jacobs P, De Wilde M, Bollen A, Collen D.
    J Biol Chem; 1987 Aug 25; 262(24):11779-84. PubMed ID: 3114253
    [Abstract] [Full Text] [Related]

  • 11. Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo.
    Geiger M, Huber K, Wojta J, Stingl L, Espana F, Griffin JH, Binder BR.
    Blood; 1989 Aug 01; 74(2):722-8. PubMed ID: 2752144
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

  • 13. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
    Vassalli JD, Dayer JM, Wohlwend A, Belin D.
    J Exp Med; 1984 Jun 01; 159(6):1653-68. PubMed ID: 6374011
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
    Declerck PJ, De Mol M, Alessi MC, Baudner S, Pâques EP, Preissner KT, Müller-Berghaus G, Collen D.
    J Biol Chem; 1988 Oct 25; 263(30):15454-61. PubMed ID: 2459123
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3.
    Stief TW, Radtke KP, Heimburger N.
    Biol Chem Hoppe Seyler; 1987 Oct 25; 368(10):1427-33. PubMed ID: 3501295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Competition of activated protein C and urokinase for a heparin-dependent inhibitor.
    Geiger M, Heeb MJ, Binder BR, Griffin JH.
    FASEB J; 1988 Apr 25; 2(7):2263-7. PubMed ID: 3350241
    [Abstract] [Full Text] [Related]

  • 20. Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation.
    Hamaguchi Y, Ohi M, Sakakura Y, Miyoshi Y.
    Thromb Haemost; 1985 Aug 30; 54(2):485-9. PubMed ID: 3936218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.